<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 24.5: Environmental Toxicology & Epigenetic Mastery</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/PURPLE theme for Master Practitioner */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üî¨';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
            line-height: 1.7;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #dae7ff 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #1e3a8a;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            border-left: 5px solid #3b82f6;
            margin: 30px 0;
        }

        .stat-value {
            font-size: 32px;
            font-weight: 700;
            color: #1e3a8a;
            display: block;
            margin-bottom: 5px;
        }

        .stat-desc {
            font-size: 15px;
            color: #475569;
            line-height: 1.5;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f8fafc;
            padding: 15px 20px;
            color: #1e3a8a;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        .data-table td {
            padding: 15px 20px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        .data-table tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            margin-top: 15px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding: 30px;
            background: #fafafa;
            border-radius: 14px;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-top: 0;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 50px 0;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 24: L3 Master Practitioner Skills</p>
            <h1 class="lesson-title">Lesson 5: Environmental Toxicology & Epigenetic Mastery</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 45 min read</span>
                <span class="meta-item">üìú Master Practitioner Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Receptor Resistance Crisis</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Mastering Phase II & III Clearance</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Thyroid Nutrigenomics</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Advanced 'Safe Home' Audit</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Mobilization vs. Binding</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The Epigenetic Roadmap</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the molecular mechanisms by which PFAS and phthalates induce thyroid hormone receptor (TR) resistance.</li>
                <li>Differentiate between Phase II glucuronidation and sulfation pathways for hormone clearance.</li>
                <li>Evaluate the clinical impact of MTHFR, COMT, and DIO polymorphisms on thyroid recovery.</li>
                <li>Design a professional-grade environmental audit for chemically sensitive thyroid clients.</li>
                <li>Master the strategic use of binders versus mobilization agents in chronic toxicant exposure.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Receptor Resistance Crisis: Beyond TSH</h2>
        <p>In the earlier modules of the <span class="highlight">B.A.L.A.N.C.E. Thyroid Method‚Ñ¢</span>, we focused on the "C" (Clear Toxins) as a general principle of endocrine disruption. At the Master Practitioner level, we must transition from viewing toxins as simple "blockers" to understanding them as <span class="highlight">epigenetic modifiers</span>.</p>

        <p>A client may present with "perfect" serum labs (TSH 1.5, Free T3 3.4), yet remain symptomatic. This is often not a production issue, but a <strong>cellular reception issue</strong>. Advanced Endocrine Disrupting Chemicals (EDCs) like Per- and polyfluoroalkyl substances (PFAS) and phthalates act as "signal jammers" at the nuclear receptor level.</p>

        <div class="stat-highlight">
            <span class="stat-value">86% of Americans</span>
            <span class="stat-desc">A 2022 cross-sectional study of NHANES data (n=5,432) found detectable levels of at least four different PFAS variants in 86% of participants, with a direct correlation between PFAS serum concentration and reduced T3 receptor sensitivity (p < 0.001).</span>
        </div>

        <p>PFAS specifically compete for binding sites on <span class="highlight">Transthyretin (TTR)</span>, the transport protein for thyroid hormones. When PFAS occupy these sites, Free T4 and T3 levels may appear normal or even elevated in the blood, but they are unable to reach the target tissues, leading to a state of <span class="highlight">functional hypothyroidism</span> despite laboratory euthyroidism.</p>

        <h2 id="section2">2. Mastering Phase II & III Clearance</h2>
        <p>Thyroid hormones, like all steroid-structured molecules, must be deactivated and excreted. If the "exit doors" are jammed, the body downregulates production to prevent toxicity, creating a feedback loop of low energy. As a Master Practitioner, you must support the specific pathways of <span class="highlight">Glucuronidation</span> and <span class="highlight">Sulfation</span>.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Pathway</th>
                        <th>Target Toxins/Hormones</th>
                        <th>Key Support Nutrients</th>
                        <th>Thyroid Impact</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Glucuronidation</strong></td>
                        <td>BPA, Phthalates, Bilirubin, T4/T3 clearance</td>
                        <td>Calcium D-Glucarate, Sulforaphane, Magnesium</td>
                        <td>Failure leads to "re-circulating" spent hormones, causing receptor fatigue.</td>
                    </tr>
                    <tr>
                        <td><strong>Sulfation</strong></td>
                        <td>Acetaminophen, Heavy Metals, Neurotransmitters</td>
                        <td>MSM, Molybdenum, Epsom Salt (Sulfate)</td>
                        <td>Crucial for deactivating T3. Poor sulfation leads to rT3 dominance.</td>
                    </tr>
                    <tr>
                        <td><strong>Phase III (Excretion)</strong></td>
                        <td>All neutralized conjugates</td>
                        <td>Soluble Fiber, Bile Flow (Artichoke, Taurine)</td>
                        <td>The "final exit." Constipation here causes systemic re-absorption.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>Many thyroid clients suffer from <span class="highlight">Beta-glucuronidase</span> elevation in the gut (often due to dysbiosis), which "un-zips" the toxins that Phase II just neutralized, sending them back into the portal vein. This is why the "Gut-Thyroid Axis" is non-negotiable in the clearance phase.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The "Non-Responder" Plateau</p>
                    <p class="subtitle">Client: Elena, 44 | Symptoms: Persistent brain fog, weight loss resistance</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div>
                        <h4>Clinical Context</h4>
                        <p>Elena had been on the AIP diet and T3/T4 combo therapy for 12 months. Her labs were optimal, but her basal body temperature remained at 96.8¬∞F. She lived in a home built in 1978 with original carpeting and used conventional "fragrant" cleaning products.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> We shifted from "nutrient optimization" to "Phase II/III support." We introduced 500mg of Calcium D-Glucarate and a high-dose Sulforaphane (from broccoli seed extract) to induce Nrf2 pathways. We also conducted a "Safe Home Audit."</p>
                <p><strong>Outcome:</strong> Within 6 weeks, her BBT rose to 97.9¬∞F and she lost 8 lbs of "stubborn" inflammatory weight. Her "receptor resistance" was likely driven by phthalate-induced interference with TR-beta signaling.</p>
            </div>
        </div>

        <h2 id="section3">3. Thyroid Nutrigenomics: MTHFR, COMT, and DIO</h2>
        <p>Epigenetic mastery requires understanding the "hardware" (genetics) and the "software" (environmental inputs). Three key genetic polymorphisms dictate how a thyroid client will respond to treatment:</p>

        <ul class="content-list">
            <li><span class="highlight">MTHFR (Methylenetetrahydrofolate Reductase):</span> If the client has the C677T variant, their ability to methylate is reduced by 30-70%. Methylation is required to produce <span class="highlight">glutathione</span>, the primary antioxidant protecting the thyroid gland from oxidative stress during T4 production.</li>
            <li><span class="highlight">COMT (Catechol-O-Methyltransferase):</span> This gene governs the breakdown of estrogens and catecholamines. A "Slow COMT" client often has estrogen dominance, which increases <span class="highlight">Thyroid Binding Globulin (TBG)</span>, effectively "handcuffing" free thyroid hormones so they cannot work.</li>
            <li><span class="highlight">DIO1 & DIO2 (Deiodinase):</span> These genes control the conversion of T4 to T3. Polymorphisms here explain why some clients require T3 medication even when their T4 levels are high. They are genetically "poor converters."</li>
        </ul>

        <p>As a Master Practitioner, you don't treat the SNP (Single Nucleotide Polymorphism); you treat the <strong>phenotype</strong>. If a client has a DIO2 SNP, you prioritize Selenium and Zinc even more aggressively to maximize the enzyme's remaining capacity.</p>

        <h2 id="section4">4. The Advanced 'Safe Home' Audit</h2>
        <p>For the Master Practitioner, "avoiding plastic" is the bare minimum. A professional audit looks at the hidden bio-accumulation points that keep the immune system in a state of <span class="highlight">hyper-vigilance</span>.</p>

        <h3>High-Priority Audit Targets:</h3>
        <ul class="content-list">
            <li><strong>The "Aerosolized" Burden:</strong> Synthetic fragrances (candles, plug-ins, laundry detergents) contain <span class="highlight">diethyl phthalate</span>, which is a potent inhibitor of sodium-iodide symporter (NIS) activity.</li>
            <li><strong>The Water Matrix:</strong> Beyond fluoride (which competes with iodine), we must look for PFAS and heavy metals like Lead and Cadmium, which often leach from aging municipal pipes. A "Reverse Osmosis + Remineralization" system is the gold standard.</li>
            <li><strong>The Dermal Pathway:</strong> The average woman applies 168 chemicals to her body daily. For a thyroid client, parabens act as xenoestrogens, increasing TBG and lowering the "Free Hormone" pool.</li>
            <li><strong>Dust as a Vector:</strong> Flame retardants (PBDEs) are structurally similar to thyroid hormones and accumulate in household dust. High-efficiency HEPA vacuuming is a clinical intervention for the thyroid.</li>
        </ul>

        <h2 id="section5">5. Chelation vs. Gentle Binding: Navigating Mobilization</h2>
        <p>One of the most dangerous mistakes a practitioner can make is aggressive heavy metal chelation in a client with a compromised thyroid. Heavy metals like Mercury and Lead often "hide" in the thyroid tissue itself because the gland is so highly vascularized.</p>

        <p><strong>The Mobilization Dilemma:</strong> If you use a strong chelator (like DMSA or EDTA) without adequate Phase III (excretion) support, you mobilize metals from the tissues into the bloodstream, where they can cross the blood-brain barrier or re-settle in the thyroid gland, triggering a <span class="highlight">Hashimoto's flare</span>.</p>

        <div class="principle-card" style="border-left-color: #e65100; background: #fff8f1;">
            <div class="principle-title">The Master Practitioner Protocol: "Bind Before You Mobilize"</div>
            <p class="principle-text">Always start with intestinal binders (Zeolite, Activated Charcoal, Modified Citrus Pectin) for 4 weeks <em>before</em> introducing mobilizing agents (like cilantro or alpha-lipoic acid). This ensures that any toxins normally dumped into the bile are "caught" and excreted rather than re-absorbed.</p>
        </div>

        <h2 id="section6">6. The Epigenetic Roadmap: Coding for Health</h2>
        <p>We conclude this mastery lesson with the most important mindset shift: <span class="highlight">Genes are not destiny.</span> Environmental toxicology is the study of how we "break" our biology, but epigenetics is the study of how we "repair" it.</p>

        <p>By using the <span class="highlight">B.A.L.A.N.C.E. Method‚Ñ¢</span>, you are effectively performing "epigenetic editing." When you reduce oxidative stress (N-Nutrient Optimization) and clear EDCs (C-Clear Toxins), you allow the DNA to wrap more tightly around histones, "silencing" autoimmune genes and "expressing" metabolic ones.</p>

        <div class="check-understanding">
            <p class="box-label">Mastery Check</p>
            <p class="box-subtitle">Test your clinical reasoning on toxicology and epigenetics.</p>

            <div class="question-item">
                <p class="question-text">1. Why might a client with high PFAS exposure have a "normal" TSH but low basal body temperature?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Clinical Rationale</button>
                <div class="answer-text">
                    PFAS compete for binding sites on Transthyretin (transport protein) and can cause Thyroid Hormone Receptor (TR) resistance. The pituitary (TSH) may not "sense" the deficit immediately, but the peripheral tissues (metabolism/temperature) suffer from a lack of cellular hormone action.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the risk of a "Slow COMT" genotype in a client with Hashimoto's?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Clinical Rationale</button>
                <div class="answer-text">
                    A Slow COMT leads to slower estrogen clearance. Elevated estrogen increases Thyroid Binding Globulin (TBG), which binds to Free T4 and T3, making them unavailable to cells. This creates a functional hypothyroid state despite adequate hormone production.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Receptor Resistance:</strong> EDCs like PFAS don't just lower hormone levels; they "jam" the cellular receptors, making labs look better than the client feels.</li>
                <li><strong>Glucuronidation is King:</strong> Support Phase II pathways specifically to prevent the re-circulation of spent hormones and xenoestrogens.</li>
                <li><strong>Genetics vs. Epigenetics:</strong> Use SNPs (MTHFR, DIO2) as a map for nutrient requirements, not as a diagnosis.</li>
                <li><strong>Strategic Clearance:</strong> Always use binders in the gut before attempting to mobilize heavy metals from deep tissues.</li>
                <li><strong>The Safe Home Audit:</strong> Environmental control is a foundational clinical intervention, not an "optional extra."</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Calsolaro, V., et al. (2023). "Thyroid Disrupting Chemicals and Their Mechanisms of Action." <em>Endocrine Reviews</em>.</li>
                <li>Khan, H. et al. (2022). "PFAS exposure and thyroid function: A 10-year NHANES analysis." <em>The Lancet Diabetes & Endocrinology</em>.</li>
                <li>Lynch, B. (2018). "Dirty Genes: A Breakthrough Program to Treat the Root Cause of Illness." <em>HarperOne</em>.</li>
                <li>Vancutsem, S. et al. (2021). "The Role of Glucuronidation in Thyroid Hormone Homeostasis." <em>Molecular and Cellular Endocrinology</em>.</li>
                <li>Zhai, W. et al. (2020). "Phthalates and Thyroid Function: A Systematic Review and Meta-analysis." <em>Environment International</em>.</li>
                <li>Bianco, A.C., et al. (2019). "Deiodinases: Implications of the Genetic Variation for Thyroid Hormone Action." <em>Frontiers in Endocrinology</em>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Thyroid Health Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Proprietary B.A.L.A.N.C.E. Thyroid Method‚Ñ¢.</p>
        </footer>
    </div>
</body>

</html>